Dopamine release in prefrontal cortex in response to β-amyloid activation of α7∗ nicotinic receptors
- 28 November 2007
- journal article
- Published by Elsevier BV in Brain Research
- Vol. 1182, 82-89
- https://doi.org/10.1016/j.brainres.2007.08.079
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer DiseasePublished by Elsevier BV ,2006
- Amyloid-β Peptide Inhibits Activation of the Nitric Oxide/cGMP/cAMP-Responsive Element-Binding Protein Pathway during Hippocampal Synaptic PlasticityJournal of Neuroscience, 2005
- β-Amyloid peptide25–35 depresses excitatory synaptic transmission in the rat basolateral amygdala “in vitro”Neurobiology of Aging, 2005
- Certain Inhibitors of Synthetic Amyloid β-Peptide (Aβ) Fibrillogenesis Block Oligomerization of Natural Aβ and Thereby Rescue Long-Term PotentiationJournal of Neuroscience, 2005
- Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's diseaseProceedings of the National Academy of Sciences of the United States of America, 2005
- Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine releaseNeuropharmacology, 2005
- Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical FunctionsBiological Psychiatry, 2004
- Comparison of dopamine and noradrenaline release in mouse prefrontal cortex, striatum and hippocampus using microdialysisNeuroscience Letters, 1999
- Soluble pool of A? amyloid as a determinant of severity of neurodegeneration in Alzheimer's diseaseAnnals of Neurology, 1999
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999